Key facts
- This page summarizes Gail Boudreaux's Form 4 filing for Elevance Health, Inc. (ELV).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Mar 2026, 16:56.
Gail Boudreaux - 02 Mar 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- ELV
- Reported as of
- 02 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Mar 2026, 16:56:45 UTC
- Prior SEC filing
- 18 Jul 2025
- Next SEC filing
- 13 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathleen S. Kiefer, Attorney in fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gail Boudreaux filed Form 4 for Elevance Health, Inc. (ELV) on 04 Mar 2026.
Change
- Previous filing in this sequence was filed on 18 Jul 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001287920
Primary reporting owner
BOUDREAUX GAIL
- Relationship
- President and CEO, Director
- Address
- 220 VIRGINIA AVENUE, INDIANAPOLIS
- Signature
- /s/ Kathleen S. Kiefer, Attorney in fact
- Signature date
- 04 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELV
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -6,713
- Change %
- -4.4%
- Price
- $294.07*
- Shares after
- 144,307
- Date
- 02 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
ELV
transaction
Common Stock
Award
- Transaction value
- Shares
- +16,153
- Change %
- +11%
- Price
- $0.000000*
- Shares after
- 160,460
- Date
- 02 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
ELV
transaction
Common Stock
Award
- Transaction value
- Shares
- +10,527
- Change %
- +6.6%
- Price
- $0.000000*
- Shares after
- 170,987
- Date
- 02 Mar 2026
- Ownership
- Direct
- Footnotes
- F3
ELV
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -1,736
- Change %
- -1%
- Price
- $284.03*
- Shares after
- 169,251
- Date
- 03 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
ELV
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 60
- Date
- 02 Mar 2026
- Ownership
- Shares Held in Spouse's Revocable Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ELV
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +63,818
- Change %
- Price
- $0.000000*
- Shares after
- 63,818
- Date
- 02 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 63,818
- Exercise price
- $294.07
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2
Represents restricted share units. Restrictions lapse as follows: 5,384 shares each on 3/2/2027 and 3/2/2028 and 5,385 shares on 3/2/2029.
Footnote F3
Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
Footnote F4
The option represents a right to purchase a total of 63,818 shares, and is exercisable in three annual installments, with one installment of 21,272 shares and two installments of 21,273 shares each, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.